clinion

Insights / Awards

Clinion eCOA: A Finalist For The Citeline Award

Clinion Citeline award 2021

Clinion eCOA earned a finalist spot at the 2021 Citeline Awards (previously known as the CARE Awards) for Best Patient-Facing Technology Initiative – a testament to our innovation in advancing patient engagement and operational excellence in clinical research.

Why Clinion Stands Out

Scalable for Global Trials

Proven across 14,000+ patients, Clinion ePRO scales seamlessly from single-site to global studies. Available on iOS, Android, and web, it ensures consistent performance and efficient data collection anywhere in the world.


Designed for Flexibility

Deployed as a standalone solution or integrated with Clinion EDC, it adapts to every trial’s needs – enabling secure, streamlined, and synchronized patient-reported data capture.


Effortless Patient Experience
With a simple, multilingual interface and BYOD model, Clinion ePRO makes participation easy and engaging. Automated reminders and real-time updates keep patients involved, boosting compliance and data quality.


With COVID-19 disrupting clinical trials and the life sciences industry, technology has emerged as the bridge to decentralization – mitigating inefficiencies of traditional approaches and integrating research seamlessly into patients’ daily lives. This recognition reaffirms our mission to empower life sciences organizations with breakthrough innovations and cross-stakeholder partnerships to facilitate decentralized trials, thereby greatly improving patient engagement and enhancing protocol adherence and outcomes.Manuj Vangipurapu, Founder & CEO of Clinion

Why This Award Matters

Being named a finalist affirms our vision to bring patients closer to research – where technology empowers participation and transforms outcomes. Clinion’s eCOA redefines the patient experience by turning engagement into a seamless, everyday interaction rather than an obligation. This recognition reflects our ongoing mission to make clinical research more inclusive, efficient, and truly patient-driven.

Unlock the Future of Clinical Trials with Clinion.

Cut your trial costs by 35% and accelerate your time-to-market by 30%

Compliance

Fully Compliant with Global Standards

FDA,HIPAA and ISO Logos
ich ,gdpr ,eu compliant logos
Clinion’s adherence to global regulatory standards including FDA 21 CFR Part 11, HIPAA, ISO 9001:2015, ISO 27001:2013, ICH, GDPR, and EU Annex 11.